AJ Joshi, MD

Articles

Next Steps for ATA188, Research Related to EBV and Multiple Sclerosis: AJ Joshi, MD

February 17, 2022

The chief medical officer at Atara Biotherapeutics provided insight on the future direction of its investigational agent ATA188 following new data that suggested a link between Epstein-Barr virus and multiple sclerosis. [WATCH TIME: 4 minutes]

ATA188, Targeting EBV Antigens to Treat Progressive MS: AJ Joshi, MD

February 11, 2022

The chief medical officer at Atara Biotherapeutics discussed the investigational agent ATA188, its mechanism to treat multiple sclerosis, and what to look for in its upcoming EMBOLD trial data readout. [WATCH TIME: 4 minutes]

Understanding the Epidemiological Connection Between MS and Epstein-Barr Virus: AJ Joshi, MD

February 09, 2022

The chief medical officer at Atara Biotherapeutics detailed the clinical significance of a recently published paper in Nature that adds to the evidence that Epstein-Barr virus is the leading cause of multiple sclerosis. [WATCH TIME: 3 minutes]